Venous thromboembolic events in patients with lung cancer treated with cisplatin-based versus carboplatin/nedaplatin-based chemotherapy.

Mitani A, Jo T, Yasunaga H, Sakamoto Y, Hasegawa W, Urushiyama H, Yamauchi Y, Matsui H, Fushimi K, Nagase T. Venous thromboembolic events in patients with lung cancer treated with cisplatin-based versus carboplatin/nedaplatin-based chemotherapy. Anticancer Drugs. 2018 07; 29(6):560-564.

View in: PubMed

subject areas

Adult
Aged
Antineoplastic Combined Chemotherapy Protocols
Carboplatin
Cisplatin
Female
Humans
Japan
Lung Neoplasms
Male
Middle Aged
Organoplatinum Compounds
Retrospective Studies
Risk
Venous Thromboembolism
Young Adult

authors with profiles

Yasuhiro Yamauchi

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support